Şunu aradınız:: vinca (İngilizce - Danca)

vinca
singrøn

vinca alkaloids
vinkaalkaloider

vinca alkaloids:
vincaalkaloider:

dose reduction of vinca alkaloids
geometrisk gennemsnitlig ændring (%)

vinca alkaloids (cyp3a4 substrates):
vinkaalkaloider (cyp3a4 substrater):

vinca alkaloid concentrations may increase.
koncentrationerne af vinkaalkaloider kan stige.

complete the dismantling of the vinca research reactor.
nedlukningen af vincaforskningsreaktoren skal føres til ende.

vinca alkaloids (e.g., vincristine and vinblastine)
vinkaalkaloider (f.eks. vincristin og vinblastin) [cyp3a4 substrate]

hypersensitivity to the active substance or other vinca alkaloids.
overfølsomhed over for det aktive stof eller over for andre vinca-alkaloider.

cardiac effects are a known class effect of the vinca alkaloids.
påvirkninger af hjertet er kendte klasseeffekter af vinca-alkaloider.

vinca alkaloids (vincristine, vinblastine) (p-gp substrates)
vinkaalkaloider (vincristin, vinblastin) (p-gp-substrater)

vincristine, vinblastine and other vinca alkaloids (used to treat cancer)
vincristin, vinblastin og andre vinca alkaloider (anvendt i cancerbehandling)

vinca alkaloids (e.g., vincristine and vinblastine) [cyp3a4 substrates]
vinkaalkaloider (f.eks. vincristin og vinblastin) [cyp3a4-substrater]

if co-administered, then it is recommended that dose adjustment of vinca alkaloids be considered.
ved samtidig administration anbefales det at overveje dosisjustering af vincaalkaloider.

vinca minor extract is an extract of the herb and leaves of the periwinkle, vinca minor, apocynaceae
vinca minor extract er en ekstrakt af urten og bladene fra vintergrøn, vinca minor, apocynaceae

vinca alkaloids (e.g., vincristine and vinblastine) (used in treating cancer)
vinkaalkaloider (f.eks. vincristin og vinblastin) (medicin mod cancer)

therefore, concomitant use of posaconazole and vinca alkaloids should be avoided unless the benefit to the patient outweighs the risk.
vincaalkaloider bør derfor undgås, medmindre fordelen for patienten opvejer risikoen.

in vitro studies showed that vinflunine is a pgp-substrate like other vinca alkaloids, but with a lower affinity.
in vitro-undersøgelser viste, at vinflunin er et p-glykoprotein (pgp)-substrat ligesom andre vinca- alkaloider, men med en lavere affinitet.

constipation is a class effect of the vinca alkaloids: 11.8% of patients experienced severe constipation during treatment with vinflunine.
obstipation er en klasseeffekt af vinca-alkaloider: 12% af patienterne oplevede svær obstipation under behandlingen med vinflunin.

posaconazole may increase the plasma concentration of vinca alkaloids (e. g. vincristine and vinblastine), which may lead to neurotoxicity.
posaconazol kan øge plasmakoncentrationen af vincaalkaloider (f. eks. vincristin og vinblastin), hvilket kan føre til neurotoksicitet.